• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
water filter
WATER FILTER FOR WATER PURIFIER
DUST BAG
Small dust filter
HUMIDIFIER FILTER
Oil fume adsorption filter

Lupin launches Mycophenolate Mofetil Tablets USP

expresspharmaDecember 30, 2020

Tag: lupin , Mycophenolate Mofetil tablets , ANDA

Lupin announced the launch of Mycophenolate Mofetil Tablets USP, 500 mg, after Lupin’s alliance partner Concord Biotech received approval for its ANDA from the United States Food and Drug Administration.

Mycophenolate Mofetil Tablets USP, 500 mg, are the generic equivalent of CellCept Tablets of Roche Palo Alto, indicated for the prophylaxis of organ rejection in recipients of allogeneic kidney, heart or liver transplants, and should be used in combination with other immunosuppressants.

Mycophenolate Mofetil Tablets USP   (RLD:   CellCept) had an annual sales of approximately $87 million in the US. (IQVIA MAT October 2020).

Previous:Glenmark launches Remogliflozin + Vildagliptin FDC in India to treat Type 2 diabetes

Next:AstraZeneca and Oxford-made Covid-19 vaccine not ready for EU market approval

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Lupin launches Mycophenolate Mofetil Tablets USP | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

LGJ-200F Standard Type Pilot Freeze Dryer

LGJ-200F Standard Type Pilot Freeze Dryer
Professional Customized Non-Standard Rubber O-Ring

Professional Customized Non-Standard Rubber O-Ring
Orthopaedic bandage

Orthopaedic bandage
ginkgo biloba standardized extract

ginkgo biloba standardized extract
Certified GMP Standard10~80% Ginsenosides Panax Ginseng Extract

Certified GMP Standard10~80% Ginsenosides Panax Ginseng Extract

Rocuronium bromide USP/EP & its intermediate & Its impurity working standard

Rocuronium bromide USP/EP & its intermediate & Its impurity working standard
Marya Fully Automatic Pharmaceutical GMP Standards Sterile Soft Bag Filling Machine Provider

Marya Fully Automatic Pharmaceutical GMP Standards Sterile Soft Bag Filling Machine Provider
High standard and safety Hualan Human Prothrombin Complex without preservatives

High standard and safety Hualan Human Prothrombin Complex without preservatives
Flame Retardant Grade Expandable Polystyrene

Flame Retardant Grade Expandable Polystyrene
Non-standard customized laboratory freeze dryer

Non-standard customized laboratory freeze dryer

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service